Removing extra DNA from blood in septic shock patients
Part of Infections clinical trials.
This trial tests whether removing extra DNA from the blood can help people with septic shock. It aims to reduce inflammation and improve outcomes for those with high DNA levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have septic shock and need strong medications to keep your blood pressure up.
- Your blood has higher than normal DNA levels, or you have other signs that predict high DNA levels.
- You do not have uncontrolled bleeding or a high risk of bleeding.
- You have no recent heart attack, stroke, or blood clot in the past 2 months.
- You are not on long-term immune-suppressing drugs and do not have HIV or severely low white blood cell counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that filters blood to remove harmful pieces of DNA that can worsen sepsis. It aims to see if this treatment is safe and helps patients with severe lung infections who are on a breathing machine.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This Phase 2 trial tests an immune-boosting cell therapy (umbilical mesenchymal stromal cells) in people with septic shock—when infection causes dangerous stress on the heart and other organs. The goal is to see if this treatment can improve outcomes compared with standard care.
This study tests whether removing certain inflammation signals (cytokines) can help people with severe heart infection (infective endocarditis) who are having heart surgery soon. It may help reduce harmful inflammation around the time of surgery, but it also has several medication and health-condition requirements.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.